Announcement
15 September 2025

Call for applications: UICC's Yamagiwa-Yoshida Memorial International Cancer Study Grants

Established cancer researchers may apply for a YY Study Grant between 15 September and 17 November 2025 

UICC is opening the call for applications for the Yamagiwa-Yoshida Memorial International Cancer (YY) Study Grants from 15 September to 17 November 2025.   

The grants aim to support researchers, clinicians, epidemiologists and public health professionals who are at least two years post their PhD qualification in undertaking collaborative projects in cancer research abroad.  They are supported by the Japan National Committee for UICC, a full UICC member organisation since 1948.

The YY Study Grants offer a unique opportunity for the exchange of complementary skills and knowledge, as well as the acquisition of new research methods and techniques. Open to individuals from any country, the grants also provide opportunities for further training in research methods or techniques.  

Since its foundation in 1972, the YY Study Grants programme has facilitated the professional development of over 330 Fellows from more than 40 countries. 

 

Relevant articles

UICC awards four YY Study Grants for international cancer research

Woman in sleeveless flower dress checking lab equipment
Read more

Five individuals awarded YY Study Grants to further cancer research

Man at Istanbul University Oncology Institute looking at a computer
Read more

“Don’t Stop Believin'”: A journey from the lab bench to improving access

Pritha Paul, recipient in 2016 of a UICC-YY Fellowship grant, working in a lab
By:
Pritha Paul
Read more

Last update

Monday 15 September 2025

Share this page

Related content

Woman in sleeveless flower dress checking lab equipment

The new YY Study Grants were awarded to researchers from Argentina, India, Pakistan, and Nigeria.

Man at Istanbul University Oncology Institute looking at a computer

UICC is delighted to announce five new YY Study Grants awards from the 2023 call, allowing established cancer researchers to further their work through three-month international visits to key research institutions.